Wokingham, United Kingdom
tranScrip is a specialist consultancy firm based in the United Kingdom focused on the pharmaceutical industry. Founded in 2008, it provides a comprehensive suite of services spanning strategic insights, therapeutic expertise, and operational support throughout a product's lifecycle.
With a clear slogan, "A specialist pharmaceutical consultancy providing strategic, therapeutic and operational services across the lifecycle," the company is committed to maximizing product value through tailor-made solutions. Its team is composed of experienced physicians, scientists, and regulatory, clinical, and commercial experts, emphasizing flexibility and bespoke approaches to expedite development and commercialization, ultimately benefiting patients worldwide.
The company's strategic importance in the Biotechnology, Health Care, and Pharmaceutical industries is underscored by its recent funding. On 01 January 2021, tranScrip received a Growth Equity VC investment from Palatine, which will likely fuel further innovation and expansion.
RDC Clinical